To provide for a limitation on availability of funds for Department of Health and Human Services, Centers for Disease Control and Prevention Emerging and Zoonotic Infectious Diseases for fiscal year 2024.

Bill 118 hr 1963, also known as the "Limitation on Availability of Funds for CDC Emerging and Zoonotic Infectious Diseases Act," aims to place restrictions on the funding available to the Department of Health and Human Services, specifically the Centers for Disease Control and Prevention (CDC), for the fiscal year 2024. The bill focuses on limiting the funds allocated to the CDC for emerging and zoonotic infectious diseases.

The purpose of this limitation is not explicitly stated in the bill itself, but it can be inferred that the goal is to control and monitor the spending of taxpayer dollars on specific areas of public health. By placing restrictions on the funds available for emerging and zoonotic infectious diseases, Congress may be seeking to ensure that the CDC is using its resources efficiently and effectively in addressing these critical health issues.

It is important to note that this bill does not eliminate funding for the CDC's work on emerging and zoonotic infectious diseases altogether. Instead, it sets a limit on the amount of money that can be allocated to these specific areas of focus for the fiscal year 2024. This limitation may impact the CDC's ability to conduct research, surveillance, and response efforts related to emerging and zoonotic infectious diseases. Overall, Bill 118 hr 1963 represents a targeted approach to budgeting and oversight of public health funds, specifically within the CDC. It will be important for lawmakers and public health officials to closely monitor the impact of this limitation on the CDC's ability to address emerging and zoonotic infectious diseases in the coming fiscal year.